Sujay Kango

Chief Executive Officer bij Tmunity Therapeutics, Inc.

Vermogen: - $ op 31-01-2024

60 jaar

Connecties 100

Health Technology

Consumer Services

Health Services

Momenteel actieve connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Justin File	M	53	MEI PHARMA, INC.	1 jaar
Tom Glocer	M	63	MERCK & CO., INC.	17 jaar
Rebecca Roberts	F	71	ABBVIE INC.	6 jaar
Carl June	M	70	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-
Melody Meyer	F	66	ABBVIE INC.	7 jaar
Dalton Smart	M	58	MERCK & CO., INC.	15 jaar
Chirfi Guindo	M	58	MERCK & CO., INC.	13 jaar
Denise Williams	F	-	MERCK & CO., INC.	15 jaar
James Flynn	M	43	MEI PHARMA, INC.	1 jaar
Caroline Ruiz	F	-	MEI PHARMA, INC.	2 jaar
Jason Sausser	M	-	MEI PHARMA, INC.	2 jaar
Steven Graziano	M	-	MERCK & CO., INC.	18 jaar
Taheer Mehboob Datoo	M	33	MEI PHARMA, INC.	1 jaar
Steven Wood	M	41	MEI PHARMA, INC.	1 jaar
Judith Li	F	40	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-
Pamela Eisele	F	-	MERCK & CO., INC.	15 jaar
Beth Seidenberg	M	67	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-
Sanat Chattopadhyay	M	-	MERCK & CO., INC.	15 jaar
Anne Frese	F	-	MEI PHARMA, INC.	2 jaar
Garry Nicholson	M	69	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	5 jaar
Patrick M. Gray	M	75	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	5 jaar
Jorge Conde	M	47	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	5 jaar
Sean Parker	M	44	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	6 jaar
Li Ming	M	-	Tmunity Therapeutics, Inc. Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.	-

Meer zien

Relatiegrafiek

Connectie in verschillende bedrijven

Oude connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
N. Coles	M	63	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	5 jaar
Lawrence Bloch	M	58	INFINITY PHARMACEUTICALS, INC.	11 jaar
Brian Drazba	M	63	MEI PHARMA, INC.	6 jaar
David J. Scott	M	71	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	-
Fred Hassan	M	78	MERCK & CO., INC.	6 jaar
Daniel Gold	M	70	MEI PHARMA, INC.	13 jaar
Christine Anna White	M	72	MEI PHARMA, INC.	13 jaar
William Ringo	M	78	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 jaar
Thomas Robert Cech	M	76	MERCK & CO., INC.	-
Thomas Wiggans	M	72	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	8 jaar
Wendy Yarno	F	69	MERCK & CO., INC.	9 jaar
Vito Palombella	M	61	INFINITY PHARMACEUTICALS, INC.	12 jaar
Kenneth F. Bartizal	M	72	MERCK & CO., INC.	20 jaar
Natarajan Sethuraman	M	62	MERCK & CO., INC.	10 jaar
Tamar Howson	F	75	MEI PHARMA, INC.	4 jaar
Craig Thompson	M	71	MERCK & CO., INC.	10 jaar
Carole A. Sable	M	62	MERCK & CO., INC.	16 jaar
Ismail Kola	M	67	MERCK & CO., INC.	4 jaar
Jaren Madden	F	-	INFINITY PHARMACEUTICALS, INC.	7 jaar
Ofir Moreno	M	-	MEI PHARMA, INC.	12 jaar
Robert Iannone	M	57	MERCK & CO., INC.	6 jaar
Jean-Marie Canan	M	68	MERCK & CO., INC.	5 jaar
Samuel Agresta	M	51	INFINITY PHARMACEUTICALS, INC.	5 jaar
Sriram Ryali	M	43	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	4 jaar
Gwen A. Fyfe	M	72	INFINITY PHARMACEUTICALS, INC.	4 jaar
Julie Gerberding	M	69	MERCK & CO., INC.	-
Magnus Åke Lundberg	M	68	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	13 jaar
Cheryl L. Cohen	F	58	MEI PHARMA, INC.	2 jaar
Caroline Dorsa	F	64	MERCK & CO., INC.	22 jaar
Wendell Wierenga	M	76	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	17 jaar
Leslie Brun	M	72	MERCK & CO., INC.	13 jaar
Carlos Eduardo Represas de Almeida	M	78	MERCK & CO., INC.	-
Kevan E. Clemens	M	80	MEI PHARMA, INC.	7 jaar
Christopher M. Lindblom	M	52	INFINITY PHARMACEUTICALS, INC.	-
Helen Torley	M	61	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 jaar
Pablo Cagnoni	M	60	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 jaar
Richard Henriques	M	68	MERCK & CO., INC.	27 jaar
William N. Kelley	M	84	MERCK & CO., INC.	-
Harry R. Jacobson	M	76	MERCK & CO., INC.	3 jaar
David Anstice	M	75	MERCK & CO., INC.	5 jaar
Steven Goldstone	M	78	MERCK & CO., INC.	6 jaar
Paul Goddard	M	74	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	16 jaar
Eric S. Lander	M	67	INFINITY PHARMACEUTICALS, INC.	10 jaar
Antonio J. Grillo-López	M	84	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	11 jaar
Adele D. Ambrose	F	67	MERCK & CO., INC.	-
Rita Karachun	F	63	MERCK & CO., INC.	14 jaar
Terrie Curran	F	55	MERCK & CO., INC.	4 jaar
James F. Fuqua	M	-	MERCK & CO., INC.	31 jaar
Karen Ling	F	60	MERCK & CO., INC.	6 jaar
Michael Samar	M	51	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	-
Sheela Mohan-Peterson	F	61	MERCK & CO., INC.	5 jaar
Flavia Borellini	M	65	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	1 jaar
Lisa Escudero	F	62	MERCK & CO., INC.	18 jaar
Francesco Maria Lavino	M	51	MERCK & CO., INC.	2 jaar
Jason Pesile	M	50	MERCK & CO., INC.	2 jaar
Zane Yang	M	-	MERCK & CO., INC.	3 jaar
Ernesto Aycardi	M	61	MERCK & CO., INC.	11 jaar
Lawrence D. Senour	M	59	MERCK & CO., INC.	-
Gregory L. Tewalt	M	-	MERCK & CO., INC.	18 jaar
Robert van Schoick	M	73	MERCK & CO., INC.	28 jaar
Peter Kellogg	M	67	MERCK & CO., INC.	7 jaar
Dennis Erb	M	-	MERCK & CO., INC.	-
Steven Hubrig Koehler	M	73	MERCK & CO., INC.	2 jaar
Mervyn Turner	M	77	MERCK & CO., INC.	2 jaar
Lars Kåre Viksmoen	M	75	MERCK & CO., INC.	14 jaar
Barry Gumbiner	M	68	MERCK & CO., INC.	6 jaar
Christopher Garland	M	-	MERCK & CO., INC.	-
Stijn Michiel Ehren	M	-	MERCK & CO., INC.	-
Richard Murray	M	65	MERCK & CO., INC.	5 jaar
Mark Stejbach	M	61	MERCK & CO., INC.	21 jaar
Joan Wainwright	F	63	MERCK & CO., INC.	6 jaar
Piotr Bobrowicz	M	-	MERCK & CO., INC.	-
Lee Ausburn	F	-	MERCK & CO., INC.	26 jaar
Silvana Battaglia	F	56	MERCK & CO., INC.	10 jaar
Marcia Avedon	M	62	MERCK & CO., INC.	4 jaar
Mirian Graddick-Weir	M	69	MERCK & CO., INC.	12 jaar

Statistieken

Land	Connecties	% van het totaal
Verenigde Staten	100	100.00%

Ouderdom van de connecties

Actief

Verleden

Man

Vrouw

Besturend

Uitvoerend

Oorsprong van de connecties

Beurs
Insiders
Sujay Kango
Persoonlijk netwerk